首页> 外文会议>ICRAM 2012 >PLGA Nanoparticles for Anti Tuberculosis Drug Delivery
【24h】

PLGA Nanoparticles for Anti Tuberculosis Drug Delivery

机译:PLGA纳米粒子用于抗结核药物递送

获取原文

摘要

Nanoparticles-based drug delivery systems have considerable potential for the treatment of tuberculosis (TB). A series of PLGA polymers with different molar feed ratios (P2:87/13, P3:83/17, P5:63/37, P6:76/24, P9:53/47) were synthesized by direct melt poly condensation method. The resulting biodegradable polymers were characterized by FTIR and ~1H NMR spectroscopy. The preparation of the drug (Pyrazinamide (PZA)) encapsulated PLGA polymers were carried out by double emulsion - solvent evaporation technique. The drug loaded PLGA-NPs were analyzed by UV-visible spectroscopy and scanning electron microscopy. The drug loading efficiency and drug release kinetics varies in the following order: P9>P5>P6>P3>P2. Among the formulations, PP9 showed a uniform as well as sustained drug release. The drug release kinetics has been evaluated by Zero-order, First order, Higuchi and Koresmeyer- Peppas models and the release mechanism has also been investigated.
机译:基于纳米颗粒的药物递送系统具有相当大的治疗结核病(TB)的潜力。通过直接熔融聚缩合法合成了一系列具有不同摩尔进料比的PLGA聚合物(P2:87/13,P3:83/17,P5:63/37,P6:76/24,P9:53/47)。通过FTIR和〜1H NMR光谱表征得到的可生物降解的聚合物。通过双乳液 - 溶剂蒸发技术进行药物(吡嗪酰胺(PZA))包封的PLGA聚合物。通过UV可见光谱和扫描电子显微镜分析药物负载的PLGA-NP。药物加载效率和药物释放动力学以下列顺序变化:P9> P5> P6> P3> P2。在制剂中,PP9显示出均匀的和持续的药物释放。药物释放动力学已经通过零阶,第一阶,Higuchi和Koresmeyer-Peppas模型进行了评估,并且还研究了释放机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号